1 active not recruiting, 1 completed, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow NTRK Family Gene Mutation: new trials by email Literature Review of NTRK Family Gene Mutation trials Research Report on NTRK Family Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING) Data collection and quality of life questionnaire - Cancer, Cancer Metastatic | Unknown | Centre Leon Berard | 500 | 2021-06-22 | 2021-08-02 | |
| Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion NTRK Family Gene Mutation | Completed | iOMEDICO AG | 88 | 2020-12-02 | 2025-05-01 | |
| Genetic Testing in Guiding Treatment for Patients With Brain Metastases Abemaciclib, PI3K Inhibitor paxalisib, Entrectinib - CDK Gene Mutation, Metastatic Malignant Neoplasm in the Brain | Phase 2 | Active not recruiting | Alliance for Clinical Trials in Oncology | 50 | 2019-10-17 | 2026-10-30 |
Neoplasm Metastasis (2) · Brain Neoplasms (1) · Neoplasms (1)
Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1)
Data Collection (1) · abemaciclib (1) · adagrasib (1) · entrectinib (1)
Alliance for Clinical Trials in Oncology (1) · Centre Leon Berard (1) · iOMEDICO AG (1)
Germany (2) · Austria (1) · Czechia (1) · Denmark (1) · France (1) · Italy (1) · Netherlands (1) · Poland (1) · Slovenia (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Benjamin Kasenda, PD Dr. Dr. (1) · Priscilla Brastianos, MD (1)
U10CA180821 (1)